Still doing great since Rituxan !
- Condition
- ME/CFS
- At worst
- Very severe (bedbound, unable to do basic care)
- Ill for
- Not stated
- Published
- Jun 2015
Summary
Self-described severe/very-severe ME, she followed the Norwegian Haukeland Rituximab schedule (1g infusions across day 0 through week 60). One month in she reported a mixed picture — some autoimmune-type symptoms improving, but cognitive impairment and orthostatic intolerance unchanged, with signs she read as ongoing autoimmune tissue damage. Later in the protocol she reported benefit similar to another patient's (clearer thinking, less fatigue, better autonomic function) "though not as well," with only minor skin-texture side effects.
Similar stories
-
Björn recovered from severe ME with antivirals (valganciclovir, ritonavir and isentress)
Ran a long multi-drug protocol: valganciclovir at 450mg twice daily for a year then a lower maintenance dose for another 8 months, repeated after HHV-6 reactivated again; famciclovir 500mg three times daily for 6 months; gammaglobulin infusions every three…
-
3-month IVIG experience
Did two years of IVIG (July 2016 to July 2018) at 82g per infusion cycle, run at a very slow infusion speed of 40 ("but it was the fastest that I could tolerate"), for autoimmunity, MCAS and dysautonomia that included years of muscle weakness and breathing…
-
The Temporary Recovery Stories (Judith)
Commenter Judith described multiple remissions and relapses since childhood, including a Rituximab course that caused complications. She now manages with AHCC, magnesium, Plaquenil and colchicine, and describes the illness as progressive, each relapse…
-
Rituxan Number Three, Some Improvement, Still Early to Tell
Previously bed- and wheelchair-bound with complex neuroimmune disease, EDS, PID, NK-cell deficiency and MCAS, she had two Rituximab infusions in November 2018 and a third by March 2019. By the 3-month mark she reported clearly improved muscle strength and…